Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-Mutant Melanoma. Schuler M, Zimmer L, Kim KB, Sosman JA, et al. Clin Cancer Res 2022 Mar 16. pii: 682197. doi: 10.1158/1078-0432.CCR-21-3872.

Read + Share

Amedeo Smart

Independent Medical Education

Schuler M, Zimmer L, Kim KB, Sosman JA, et al. Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-Mutant Melanoma. Clin Cancer Res 2022 Mar 16. pii: 682197. doi: 10.1158/1078-0432.CCR-21-3872.
PMID: 35294522